• Brown J, Crawford TJ, Datta S, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD001019. DOI: 10.1002/14651858.CD001019.pub3.
• Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A. Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No.: CD004753. DOI: 10.1002/14651858.CD004753.pub4
• Brown J, Kives S, Akhtar M. Progestagens and anti‐progestagens for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD002122. DOI: 10.1002/14651858.CD002122.pub2.
• Brown J, Pan A, Hart RJ. Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD008475. DOI: 10.1002/14651858.CD008475.pub2.
• Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD001019. DOI: 10.1002/14651858.CD001019.pub2.
• Dunselman, G., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D’Hooghe, T., & De Bie, B. et al. (2014). ESHRE guideline: management of women with endometriosis. Human Reproduction, 29(3), 400-412. doi: 10.1093/humrep/det457
• Farquhar C, Prentice A, Singla AA, Selak V. Danazol for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD000068. DOI: 10.1002/14651858.CD000068.pub2.
• Ferreira, R., Vieira, C., Rosa-e-Silva, J., Sá Rosa-e-Silva, A., Nogueira, A., & Ferriani, R. (2010). Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception, 81(2), 117-122. doi: 10.1016/j.contraception.2009.08.003
• Furness S, Yap C, Farquhar C, Cheong YC. Pre and post‐operative medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD003678. DOI: 10.1002/14651858.CD003678.pub2.
• Gomes, M., Ferriani, R., Rosa e Silva, J., Japur de Sá Rosa e Silva, A., Vieira, C., & Cândido dos Reis, F. (2007). The levonorgestrel-releasing intrauterine system and endometriosis staging. Fertility And Sterility, 87(5), 1231-1234. doi: 10.1016/j.fertnstert.2006.11.044
• Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vanderkerchove P. Ovulation suppression for endometriosis for women with subfertility. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD000155. DOI: 10.1002/14651858.CD000155.pub2.
• Moore, A. (2018, July 02). What’s the point of paracetamol? Retrieved from https://theconversation.com/whats-the-point-of-paracetamol-66808
• Nawathe A, Patwardhan S, Yates D, et al. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008; 115:818. https://doi.org/10.1111/j.1471-0528.2008.01740.x
• Petta, C., Ferriani, R., Abrao, M., Hassan, D., Rosa e Silva, J., Podgaec, S., & Bahamondes, L. (2005). Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Human Reproduction, 20(7), 1993-1998. doi: 10.1093/humrep/deh869
• Patwardhan, S., Nawathe, A., Yates, D., Harrison, G., & Khan, K. (2008). Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG: An International Journal Of Obstetrics & Gynaecology, 115(7), 818-822. doi: 10.1111/j.1471-0528.2008.01740.x